Radiopharmaceuticals in cardiology
Nuclear Medicine Review · 2012
DOI: 10.5603/nmr-18729 ↗At a glance
Übersichtsarbeit in Nuclear Medicine Review, 2012. Written by Renata Mikołajczak and 1 co-authors. Institution: National Centre for Nuclear Research, Radioisotope Centre POLATOM, 7 Andrzeja Sołtana St., 05–400 Otwock, Poland. r.mikolajczak@polatom.pl. Major MEDLINE topics: Radiopharmaceuticals. Cited 1 times so far (Crossref).
Abstract (original language)
Myocardial perfusion studies are among the most often performed investigations in Nuclear Medicine. However, the development of radiopharmaceuticals for cardiology is an emerging discipline and several other radiotracers have been proven to be useful. Although the myocardial perfusion studies have a well established role in the management of cardiac disorders, still a number of radiopharmaceuticals are under development for a variety of specific cardiac indications and their eventual clinical role remains to be seen. The paper provides a short overview of currently used radiopharmaceuticals and potential molecular imaging radiotracers applicable in cardiology.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- National Centre for Nuclear Research, Radioisotope Centre POLATOM, 7 Andrzeja Sołtana St., 05–400 Otwock, Poland. r.mikolajczak@polatom.pl
Cite
APA
Mikołajczak, R., & Garnuszek, P. (2012). Radiopharmaceuticals in cardiology. Nuclear Medicine Review. https://doi.org/10.5603/nmr-18729
Vancouver
Mikołajczak R, Garnuszek P. Radiopharmaceuticals in cardiology. Nuclear Medicine Review. 2012. doi:10.5603/nmr-18729
BibTeX
@article{Mikoajczak2012,
author = {Mikołajczak, Renata and Garnuszek, Piotr},
title = {Radiopharmaceuticals in cardiology},
journal = {Nuclear Medicine Review},
year = {2012},
doi = {10.5603/nmr-18729}
}
EUVIMED